| PB test | Paul Bunnell test |
|---|---|
| PB | British pharmacopeia [Pharmacopoeia Britannica]; paraffin bath; Paul-Bunnell [antibody]; periodic br... |
| PBT | Paul-Bunnell test; phenacetin breath test; piebald trait; profile-based therapy |
| REV | reticuloendotheliosis virus |
| ReV | regulator of virion |
| P-B | Paul--Bunnell |
|---|---|
| RRE | REV response element |
| REV | Reticuloendotheliosis virus |
| REV-T | Reticuloendotheliosis virus strain T |
| RRE | Rev Responsive Element |
| grateful med | A microcomputer-based software package providing a user-friendly interface to the medlars system of the national library of medicine. (12 Dec 1998) |
|---|---|
| gene products, rev | Trans-acting nuclear proteins whose functional expression are required for HIV viral replication. Specifically, the rev gene products are required for processing and translation of the HIV gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. Rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (car) in env, also known as the rev-responsive element (rre), is responsive to the rev gene product. Rev is short for regulator of virion. (12 Dec 1998) |
| genes, rev | DNA sequences that form the coding region for a protein that regulates the expression of the viral structural and regulatory proteins in human immunodeficiency virus (HIV). Rev is short for regulator of virion. (12 Dec 1998) |
| rev | <molecular biology> A regulatory protein produced by HIV within infected cells. Rev helps transport HIV RNA sequences (messenger RNA) out from the nucleus into the cells cytoplasm, where it directs construction of proteins for new virus particles. (11 Jan 1998) |
| Bailliart, Paul | <person> French ophthalmologist, 1877-1969. See: Bailliart's ophthalmodynamometer. (05 Mar 2000) |
| Berg, Paul | <person> An American biochemist born in 1926, who won the Nobel Prize for developing a DNA mapping method. Also he determined that it takes two steps to oxidize fatty acids. (13 Nov 1997) |
| Bing, Paul Robert | <person> German neurologist, 1878-1956. See: Bing's reflex. (05 Mar 2000) |
| Blocq, Paul | <person> French physician, 1860-1896. See: Blocq's disease. (05 Mar 2000) |
| Blum, Paul | <person> French physician, 1878-1933. See: Gougerot and Blum disease. (05 Mar 2000) |
| Bouin, Paul | <person> French histologist, 1870-1962. See: Bouin's fixative. (05 Mar 2000) |
| Busquet, Paul | <person> French physician, *1866. See: Busquet's disease. (05 Mar 2000) |
| Mayer, Paul | <person> German histologist, 1848-1923. See: Mayer's haemalum stain, Mayer's mucicarmine stain, Mayer's mucihematein stain. (05 Mar 2000) |
| Paul-Bunnell test | Test for detection of heterophil antibodies in infectious mononucleosis. See: Forssman antigen. (05 Mar 2000) |
| Paul Ehrlich | <person> A brilliant scientist and student, born in Silesia, Germany, who at the age of 23 published his first scientific paper which was on the discovery of the mast cells - a name coined by him (1887). While a resident in medicine at Charite Hospital in Berlin he utilised the newly discovered aniline dyes to develop some of the basic methods of histology. Among his contributions are: The preparation and staining of blood smears, he demonstrated granules in leukocytes, described the neutrophil, basophil, eosinophil, myelocyte, and mononuclear cells (white blood cells), he demonstrated normoblasts, megaloblasts and microblasts of the erythrocytic (red blood cell) series. In 1887, he differentiated lymphocytic leukaemia from "bone marrow leukaemia" (myeloid) on blood smear, in 1888, he described aplastic anaemia, in 1882 the diazo reaction of typhoid urines, in 1882, less than six weeks after Koch described the Tuberculus bacillus, Ehrlich had described its acid-fastness and devised the fuchsin stain to demonstrate the pink rod on a blue background. Ehrlich fell ill with tuberculosis and went to Egypt for 3 years for rest and cure. Following his return, he entered the field of immunology. at Von Behring's request, he developed means of standardising antitoxin dosage (immunization units). at the age of 42, he became director of the "Royal Institute for Standardisation and Investigation of Antitoxic Sera." Here he devised his famous "side-chain" theory of immunisation. It has since been replaced. Paul Ehrlich reinvestigated Bordet's alexin and heat-stable substance and named them "complement" and "immune body". Ehrlich coined the terms and created a new science of chemotherapy. In 1910 he discovered Salvarsan or 606, a therapeutic antiluetic. For his silver bullet (Salvarsan) in 1908, he received the Nobel Prize. This scientist was greatly concerned over the problem of drug fastness which still remains a problem. He died August 20, 1915. Lived: 1854-1915. (18 Nov 1997) |
| Paul, Gustav | <person> Austrian physician, 1859-1935. See: Paul's reaction, Paul's test, Paul-Bunnell test. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|